← Contracts
PT
1637/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de R1100 - RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA] e R1101 - RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP;
ID 11591570
· Portal BASE
Price
Base Price
€370,691
.00
Effective Price
€2,638
.00
-99.3%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Braganca
- Bidder Count
- —
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Dates
- Publication
- 18 Jul 2025
- Celebration
- 17 Jul 2025
Contracting Entity
Unidade Local de Saúde do Nordeste, E. P. E.
NIF 509932584
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 449
- Supplier
- 253
- Number of Awards
- 4
- Rule
- A1 repeat direct award: 4 awards within 36 months
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 370691.0
- Total effective price
- 2638.0
- Ratio
- 0.0071
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0071 outside [0.5, 1.5]
Detected 2026-03-06